Skip to main content

Client News

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients

1st June 2023

Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities

31st May 2023

Mainz Biomed Expands Commercial Footprint into Poland

31st May 2023

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

31st May 2023

Destiny Pharma: Board Changes Dr Debra Barker Appointed Interim CEO

25th May 2023

ONWARD: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

25th May 2023

Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper

24th May 2023

Medigene AG: Medigene Expands Patent Portfolio for its End-to-End Platform

22nd May 2023

MIG Capital: MIG Capital strengthens its investment team with four new professionals

17th May 2023

LEON appoints Dr. Setu Kasera as Chief Scientific Officer

16th May 2023